Chugai Pharmaceutical Co(CHGCF)
$45.55+1.24 (+2.80%)
CHGCF
Chugai Pharmaceutical Co earnings date
$45.55
At close:+1.24 (+2.80%)
Chugai Pharmaceutical Co (CHGCF) Q2 2026 Earnings Report
23 Followers
CHGCF Q2 2026 EPS Results
- Actual EPS
- $0.44
- Consensus EPS
- $0.48
- Beat/Miss
- Missed by -$0.04
- One Year Ago EPS
- $0.37
CHGCF Q2 2026 Revenue Results
- Actual Revenue
- $2.16B
- Expected Revenue
- $2.15B
- Beat/Miss
- Beat by +$11.35M
- YoY Revenue Growth
- +17.79%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/24/2026
- Time
- Before Open
- Conference Call
- Friday, July 24, 2026
CHGCF Upcoming Earnings
Chugai Pharmaceutical Co's next earnings date is estimated for February 4, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CHGCF Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CHGCF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 04, 2027 | 2026 (Q4) | 0.49- | 0.49 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 0.490.59 | 0.48 | 21.81% (+0.11) | |
| Jul 24, 2026 | 2026 (Q2) | 0.480.44 | 0.37 | 18.95% (+0.07) | |
| Apr 24, 2026 | 2026 (Q1) | 0.420.44 | 0.37 | 18.68% (+0.07) | |
| Jan 29, 2026 | 2025 (Q4) | 0.470.49 | 0.35 | 40.24% (+0.14) | |
| Oct 24, 2025 | 2025 (Q3) | 0.470.48 | 0.42 | 14.67% (+0.06) | |
| Jul 24, 2025 | 2025 (Q2) | 0.470.37 | 0.43 | -14.93% (-0.06) | |
| Apr 24, 2025 | 2025 (Q1) | 0.320.37 | 0.29 | 30.67% (+0.09) | |
| Jan 30, 2025 | 2024 (Q4) | 0.370.35 | 0.35 | 0.37% (+0.00) | |
| Oct 25, 2024 | 2024 (Q3) | 0.380.42 | 0.3 | 41.15% (+0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


